CAC-Based Treatment

Uses

Comparisons

Highlighted claims

• High-risk and very-high-risk participants in the CAC-based arm start treatment during study site visits and then transition to GP-led management. — Study protocol for the investigator-initiated Danish pragmatic randomised STENO INTEN-CT trial: does screening and intervention for subclinical coronary artery disease in type 2 diabetes reduce cardiovascular events?
• Low-risk participants with CAC scores from 1 to 99 receive no specific study intervention beyond standard guideline care. — Study protocol for the investigator-initiated Danish pragmatic randomised STENO INTEN-CT trial: does screening and intervention for subclinical coronary artery disease in type 2 diabetes reduce cardiovascular events?
• Standard-arm participants and their GPs are blinded to CAC results and continue usual contemporary diabetes guideline care. — Study protocol for the investigator-initiated Danish pragmatic randomised STENO INTEN-CT trial: does screening and intervention for subclinical coronary artery disease in type 2 diabetes reduce cardiovascular events?
• Very-low-risk participants with CAC equal to zero receive recommendations for less intensive treatment, but the patient and GP make the final decision. — Study protocol for the investigator-initiated Danish pragmatic randomised STENO INTEN-CT trial: does screening and intervention for subclinical coronary artery disease in type 2 diabetes reduce cardiovascular events?
• The high-risk intervention centers on cardioprotective drug combinations that were unavailable in prior trials. — Study protocol for the investigator-initiated Danish pragmatic randomised STENO INTEN-CT trial: does screening and intervention for subclinical coronary artery disease in type 2 diabetes reduce cardiovascular events?